Advertisement
For instance, Marcus Wharton, MD will present on magnetic field-guidedablation for complex arrhythmias at 1:35 pm PDT on May 16; from the lab ofJeremy Ruskin, MD, at Massachusetts General Hospital, Arash Aryana, MD willreport on remote, guided magnetic catheter ablation of ventricular tachycardiaat 8:25 am on May 15; and Xu Chen, MD from Rigshospitalet in Copenhagen willpresent on the use of magnetic navigation in the pediatric population.
Advertisement
With this evidence of broad clinical utility as a backdrop, Stereotaxisplans to highlight the simplicity, safety, and efficacy that are enabled byits magnetic navigation and information management systems in severaladditional settings:
"With its Niobe Magnetic Navigation and Odyssey information managementsystems, Stereotaxis has built a powerful platform to advance the practice ofelectrophysiology well into the future, and we are confident that it willcontinue to transform interventional medicine in important ways," said BevilHogg, CEO of Stereotaxis. "We are delighted to see how pervasive a roleStereotaxis' platform is playing at Heart Rhythm 2008, fully independent ofour own corporate initiatives and programs, and we view this as a profoundendorsement of the simplicity, safety and efficacy of the Niobe system, asapproximately 15,000 procedures have proven in every chamber of the heart. Itis our belief that clinicians and patients will always seek out the safestalternative. We are committed to meeting this expectation of our customers,and recognize that this is our surest route to success."
Heart Rhythm 2008, the Heart Rhythm Society's 29th Annual ScientificSessions, will be held at the Moscone Center in San Francisco from May 14through May 17, 2008.
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced cardiologyinstrument control system for use in a hospital's interventional surgicalsuite to enhance the treatment of coronary artery disease and arrhythmias. TheStereotaxis System is designed to enable physicians to complete more complexinterventional procedures by providing image guided delivery of catheters andguidewires through the blood vessels and chambers of the heart to treatmentsites. This is achieved using computer-controlled, externally applied magneticfields that govern the motion of the working tip of the catheter or guidewire,resulting in improved navigation, shorter procedure time and reduced x-rayexposure. The core components of the Stereotaxis system have receivedregulatory clearance in the U.S., Europe and Canada.
This press release includes statements that may constitute"forward-looking" statements, usually containing the words "believe,""estimate," "project," "expect" or similar expressions. Forward-lookingstatements inherently involve risks and uncertainties that could cause actualresults to differ materially from the forward-looking statements. Factors thatwould cause or contribute to such differences include, but are not limited to,continued acceptance for the Company's products in the marketplace,competitive factors, changes in government reimbursement procedures,dep
